Is hysterosalpingo-foam sonography (HyFoSy) more tolerable in terms of pain and anxiety than hysterosalpingography (HSG)? A prospective real-world setting multicentre study
- PMID: 35152893
- PMCID: PMC9909448
- DOI: 10.1186/s12905-022-01606-3
Is hysterosalpingo-foam sonography (HyFoSy) more tolerable in terms of pain and anxiety than hysterosalpingography (HSG)? A prospective real-world setting multicentre study
Abstract
Background: In 60% of sterile couples a female factor is present, with these being tubal factors in 30-50% of cases. A tubal patency test is also required in women without a male partner undergoing fertility treatment. Thus, an accurate, safe and tolerable technique should be available. The aim of this study is to determine and to compare hysterosalpingo-foam sonography (HyFoSy) and hysterosalpingography (HSG) tolerability in terms of pain and anxiety.
Methods: This is a prospective real-world setting multicentre study conducted in two tertiary hospitals in Madrid. 210 infertile women/women without a male partner looking to get pregnant were recruited; 111 for the HyFoSy group and 99 for the HSG group. Tolerability was measured in terms of anxiety by the State Trait Anxiety Inventory (STAI) and pain by the Visual Analogue Scale (VAS).
Results: Median VAS score in HyFoSy group was 2 (P25; P75: 1; 3) versus 5 (4; 8) in HSG group, p < 0.001. The median State-STAI score in the HSG group was 18 points (10; 26) versus 10 (7; 16) in the HyFoSy group (p < 0.001); the median Trait-STAI score in the HSG group was 15 (11; 21) versus 13 (9; 17) in the HyFoSy group (p = 0.044).
Conclusions: HyFoSy shows higher tolerability to both: pain and anxiety. It is related to less pain and less post-test anxiety than HSG.
Keywords: Anxiety; Hysterosalpingo-foam sonography (HyFoSy); Hysterosalpingography (HSG); Pain; Tolerability.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Can hysterosalpingo-foam sonography replace hysterosalpingography as first-choice tubal patency test? A randomized non-inferiority trial.Hum Reprod. 2022 May 3;37(5):969-979. doi: 10.1093/humrep/deac034. Hum Reprod. 2022. PMID: 35220432 Free PMC article. Clinical Trial.
-
The FOAM study: is Hysterosalpingo foam sonography (HyFoSy) a cost-effective alternative for hysterosalpingography (HSG) in assessing tubal patency in subfertile women? Study protocol for a randomized controlled trial.BMC Womens Health. 2018 May 9;18(1):64. doi: 10.1186/s12905-018-0556-6. BMC Womens Health. 2018. PMID: 29743106 Free PMC article.
-
The effect of prior hysterosalpingo-foam sonography or hysterosalpingography on tubal patency: a secondary analysis of a randomized controlled trial.Hum Reprod. 2024 Nov 1;39(11):2485-2490. doi: 10.1093/humrep/deae194. Hum Reprod. 2024. PMID: 39190881 Free PMC article. Clinical Trial.
-
Clinical Aspects of HyFoSy as Tubal Patency Test in Subfertility Workup.Biomed Res Int. 2019 Jul 8;2019:4827376. doi: 10.1155/2019/4827376. eCollection 2019. Biomed Res Int. 2019. PMID: 31360713 Free PMC article. Review.
-
Is hysterosalpingo-foam sonography the new gold standard for assessing tubal patency? A systematic review and meta-analysis.Reprod Biomed Online. 2025 Jan;50(1):104380. doi: 10.1016/j.rbmo.2024.104380. Epub 2024 Jul 18. Reprod Biomed Online. 2025. PMID: 39522344
Cited by
-
Hysterosalpingo-foam sonography versus hysterosalpingography during fertility work-up: an economic evaluation alongside a randomized controlled trial.Hum Reprod. 2024 Jun 3;39(6):1222-1230. doi: 10.1093/humrep/deae071. Hum Reprod. 2024. PMID: 38600625 Free PMC article. Clinical Trial.
-
Response to Letter to the Editor From Marin et al: "The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography".J Clin Endocrinol Metab. 2023 Aug 18;108(9):e902-e903. doi: 10.1210/clinem/dgad169. J Clin Endocrinol Metab. 2023. PMID: 36948881 Free PMC article. No abstract available.
-
No pain relief by virtual reality during hysterosalpingography (HSG): results from a randomized controlled trial.Hum Reprod. 2024 Sep 1;39(9):1987-1995. doi: 10.1093/humrep/deae133. Hum Reprod. 2024. PMID: 38863305 Free PMC article. Clinical Trial.
-
Tubal flushing with oil-based contrast during hysterosalpingography versus tubal flushing by hysterosalpingo-foam sonography in infertile women undergoing fertility work-up: study protocol of a randomised controlled trial (FOil study).BMJ Open. 2024 Nov 24;14(11):e091778. doi: 10.1136/bmjopen-2024-091778. BMJ Open. 2024. PMID: 39581724 Free PMC article.
References
-
- SEF Libro Blanco Sociosanitário. La Infertilidad en España: Situación Actual y Perspectivas. 1st ed. Weinig RM, editor. Imago Concept & Image Development, S.L., Madrid; 2011.
-
- Kuohung W, Hornstein MD. Causes of female infertility: UpToDate [Internet]. https://www-uptodate-com.bvcscm.a17.csinet.es/contents/causes-of-female-.... Accessed 3 Jan 2022.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials